摘要
目的:探讨孟鲁司特在儿童支气管哮喘治疗中的疗效及安全性。方法:将60例哮喘患儿随机分成两组,治疗组在对照组基础上加用孟鲁司特。结果:治疗组远期疗效明显优于对照组(P<0.05)。结论:孟鲁司特治疗小儿支气管哮喘,可减少哮喘发作,减少倍氯米松(必可酮)用量,是临床治疗哮喘的有效方法之一。
Objective: To investigate the clinical effect of montelukast and its safety. Method: 60 cases of asthma patients were divided randomly into two groups. The treating group was treated with montelukast sodium. Results: 30 cases of asthma patients were remarkably relieved in clinical symptoms. Conclusion: Montelukast sodium can improve the clinical symptoms and the amount of beclometasone (Becotide) can be minimized.
出处
《儿科药学杂志》
CAS
2004年第3期36-37,共2页
Journal of Pediatric Pharmacy
关键词
支气管哮喘
孟鲁司特
倍氯米松
Bronical asthma
Montelukast sodium
Beclometasone
